AACR 2026: Moderna, Revolution, Zymeworks and BeOne showcase new data

Moderna, Revolution Medicines and Zymeworks record wins in melanoma, lung and breast cancers, while BeOne swings and misses at head and neck cancer.

Scroll to Top